9
Apr
2025
Nanjing Dorra Pharmaceutical Technology Co.,Ltd
Exhibitor at CPHI Japan 2025 stand 6E-29
About Us
Categories
-
CN
-
2015On CPHI since
-
2Certificates
-
50 - 99Employees
Company types
Primary activities
Event information
CPHI Japan 2025
-
09 Apr 2025 – 11 Apr 2025
-
East Halls 4, 5 & 6, Tokyo Big Sight, Tokyo, Japan
-
Visit us at stand 6E-29
Products Featured at CPHI Japan 2025
-
Product Dapagliflozin
CAS No.960404-48-2
In-house -
Product DexborneolConcentrated
CAS No.464-43-7
In-house -
Product Finerenone
CAS No.1050477-31-0
Standard:In-house -
Product Roxadustat
CAS NO:808118-40-3
In-house -
Product Vonoprazan
CAS No.1260141-27-2
In-house
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance